摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

C-(3-[6-(2-methoxy-phenyl)-pyrimidin-4-ylamino]-phenyl)-N,N-dimethyl-methanesulfonamide | 1073484-43-1

中文名称
——
中文别名
——
英文名称
C-(3-[6-(2-methoxy-phenyl)-pyrimidin-4-ylamino]-phenyl)-N,N-dimethyl-methanesulfonamide
英文别名
C-{3-[6-(2-methoxy-phenyl)-pyrimidin-4-ylamino]-phenyl}-N,N-dimethyl-methanesulfonamide;1-[3-[[6-(2-methoxyphenyl)pyrimidin-4-yl]amino]phenyl]-N,N-dimethylmethanesulfonamide
C-(3-[6-(2-methoxy-phenyl)-pyrimidin-4-ylamino]-phenyl)-N,N-dimethyl-methanesulfonamide化学式
CAS
1073484-43-1
化学式
C20H22N4O3S
mdl
——
分子量
398.486
InChiKey
CZPKDOCUGZUVEL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    28
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    92.8
  • 氢给体数:
    1
  • 氢受体数:
    7

反应信息

点击查看最新优质反应信息

文献信息

  • Inhibitors of protein kinases
    申请人:Schauerte Heike
    公开号:US20080275063A1
    公开(公告)日:2008-11-06
    The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceutical compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases.
    本发明提供了新化合物。这些化合物可用作CDK5抑制剂,因此它们可以包含在药物组合物中,用于治疗任何类型的疼痛、炎症性疾病、免疫性疾病、增殖性疾病、传染病、心血管疾病和神经退行性疾病。
  • 4, 6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES
    申请人:Wabnitz Philipp
    公开号:US20110306602A1
    公开(公告)日:2011-12-15
    The present invention relates to inhibitors of general Formula (I) of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to compounds for preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases.
    本发明涉及一般公式(I)的细胞周期依赖性激酶抑制剂及其治疗应用。此外,本发明还涉及用于预防和/或治疗任何类型的疼痛、炎症性疾病、免疫性疾病、增殖性疾病、传染性疾病、心血管疾病和神经退行性疾病的化合物。
  • 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
    申请人:Wabnitz Philipp
    公开号:US08507498B2
    公开(公告)日:2013-08-13
    The present invention relates to inhibitors of general Formula (I) of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to compounds for preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases.
    本发明涉及一般式(I)的细胞周期依赖性激酶抑制剂及其治疗应用。此外,本发明涉及用于预防和/或治疗任何类型的疼痛、炎症性疾病、免疫疾病、增殖性疾病、传染病、心血管疾病和神经退行性疾病的化合物。
  • 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES
    申请人:Ingenium Pharmaceuticals GmbH
    公开号:US20130338147A1
    公开(公告)日:2013-12-19
    The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases.
    本发明涉及抑制细胞周期依赖性激酶及其治疗应用的药物。此外,本发明涉及通过给予至少一种细胞周期依赖性激酶抑制剂的有效剂量来预防和/或治疗任何类型的疼痛、炎症性疾病、免疫性疾病、增殖性疾病、传染性疾病、心血管疾病和神经退行性疾病的方法。
  • WO2008/129069
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多